Clinical Trial Update: A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D [Phase 3]

View source ↗

Summary

Phase 3 randomized open-label trial comparing maintenance IV Monofer (iron isomaltose) given as single or repeated bolus injections with IV iron sucrose in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Monofer (Ferric derisomaltose)
• VENOFER (Iron sucrose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Chronic Kidney Disease Stage 5 (Dialysis Dependent) | Phase 3 | Status: COMPLETED | Results posted: 2015-07-24